Inventor · disambiguated record
Bohua Zhong
Also filed as: ZHONG BOHUA
7 granted patents·3 pending applications·8 citations·filing 2002–2021
73Inventor score
Files withZHONG BOHUA4BEIJING JUNKE HUAYUAN MED TECH CO LTD2TAIZHOU HUAYUAN MEDICINAL TECH CO LTD2JINGLUWEIDAI INFORMATION CONSULTING SERVICE BEIJING CO LTD1ZHEJIANG XIANJU PHARMACEUTICAL1
Top patents by PatentIndex Score
10 records- 0167US7119100B2Oripavine derivatives and their uses as pharmaceuticalsZHEJIANG XIANJU PHARMACEUTICAL·Filed 2002·Granted Oct 10, 2006·8 cites·8 claims
- 0263US12378210B2Pharmaceutical composition comprising tizoxanide and pharmaceutical use thereofBEIJING JUNKE HUAYUAN MED TECH CO LTD·Filed 2021·Granted Aug 5, 2025·0 cites·15 claims
- 0358US11358944B2Anxiolytic deuterated compound and medical use thereofBEIJING JUNKE HUAYUAN MED TECH CO LTD·Filed 2019·Granted Jun 14, 2022·0 cites·3 claims
- 0456US8318772B2Amine compounds and medical uses thereofZHONG BOHUA·Filed 2009·Granted Nov 27, 2012·0 cites·8 claims
- 0550US10759809B2Deuterated compound and medical use thereofTAIZHOU HUAYUAN MEDICINAL TECH CO LTD·Filed 2018·Granted Sep 1, 2020·0 cites·6 claims
- 0650US2012041167A1Poly(glutamic acid)-drug conjugate with an amino acid as a linkerZHONG BOHUA·Filed 2007·Application pending·0 cites
- 0741US10617679B2Deuterated compounds and medical uses thereofJINGLUWEIDAI INFORMATION CONSULTING SERVICE BEIJING CO LTD·Filed 2019·Granted Apr 14, 2020·0 cites·7 claims
- 0836US9187507B2Acyclic nucleoside phosphonate derivatives and medical uses thereofZHONG BOHUA·Filed 2010·Granted Nov 17, 2015·0 cites·16 claims
- 0936US2011306633A1Selective m4 receptor antagonist and its medical useZHONG BOHUA·Filed 2007·Application pending·0 cites
- 1033US2022185764A1Resveratrol derivative and anti-fibrotic method using the sameTAIZHOU HUAYUAN MEDICINAL TECH CO LTD·Filed 2020·Application pending·0 cites
Join the waitlist — get patent alerts
Get an alert when Bohua Zhong files or is granted a new patent.
We store only your email — no account needed. See our privacy policy.
Identity basis: PatentsView inventor disambiguation (2025Q4-odp release). How scoring works →